We are live on ! Find out more
ADVM

Adverum Biotechnologies
ADVM

Delisted

ADVM was delisted on the 8th of December, 2025.

Back to rankings

58 hedge funds and large institutions have $419M invested in Adverum Biotechnologies in 2014 Q3 according to their latest regulatory filings, with 58 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
+58
Holders Change %
–
% of All Funds
1.68%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
58
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$99.3M
2
DM
Deerfield Management
New York
+$60.9M
3
VM
VHCP Management
New York
+$41.1M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$30.7M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$21.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Marshall Wace
26
Marshall Wace
United Kingdom
$1.55M +$1.35M +4,541 New
DCM
27
Driehaus Capital Management
Illinois
$1.17M +$1.02M +3,418 New
Geode Capital Management
28
Geode Capital Management
Massachusetts
$1.16M +$1.01M +3,397 New
CC
29
CQS Cayman
Cayman Islands
$1.13M +$982K +3,300 New
Federated Hermes
30
Federated Hermes
Pennsylvania
$1.03M +$893K +3,000 New
UBS AM
31
UBS AM
Illinois
$985K +$857K +2,880 New
LOAMU
32
Lombard Odier Asset Management (USA)
New York
$854K +$744K +2,499 New
PAM
33
Panagora Asset Management
Massachusetts
$838K +$729K +2,451 New
BIM
34
BlackRock Investment Management
Delaware
$785K +$683K +2,297 New
Bank of New York Mellon
35
Bank of New York Mellon
New York
$767K +$668K +2,245 New
TCIM
36
TIAA CREF Investment Management
New York
$707K +$615K +2,067 New
EAM
37
Eventide Asset Management
Massachusetts
$684K +$595K +2,000 New
Northern Trust
38
Northern Trust
Illinois
$495K +$431K +1,448 New
SIM
39
Spark Investment Management
New York
$495K +$431K +1,450 New
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$434K +$378K +1,270 New
Deutsche Bank
41
Deutsche Bank
Germany
$326K +$284K +954 New
Morgan Stanley
42
Morgan Stanley
New York
$305K +$265K +892 New
MLICM
43
Metropolitan Life Insurance Company (MetLife)
New York
$296K +$258K +866 New
STC
44
SEI Trust Company
Pennsylvania
$275K +$239K +803 New
Bank of Montreal
45
Bank of Montreal
Ontario, Canada
$265K +$231K +776 New
TD Asset Management
46
TD Asset Management
Ontario, Canada
$256K +$223K +750 New
NFA
47
Nationwide Fund Advisors
Ohio
$252K +$219K +737 New
RSCM
48
Rock Springs Capital Management
Maryland
$246K +$214K +720 New
TA
49
Teachers Advisors
New York
$220K +$191K +643 New
D.E. Shaw & Co
50
D.E. Shaw & Co
New York
$203K +$177K +595 New
1
2
3

ADVM Hedge Fund Activity: Q3 2014 in Review

58 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q3 2014, worth a combined $419M.

Buyers outnumbered sellers: 58 funds opened new ADVM positions and 0 closed out — a net gain of 58 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $99.3M.

  • 58 institutional investors held Adverum Biotechnologies (ADVM) as of Q3 2014, up from 0 in Q2 2014.
  • Funds reported $419M of Adverum Biotechnologies stock for Q3 2014.
  • 58 funds opened new Adverum Biotechnologies positions in Q3 2014 and 0 closed out, a net change of +58 holders.
  • The largest Adverum Biotechnologies buyer in Q3 2014 was Fidelity Investments, an estimated $99.3M added.

Based on aggregated 13F filings for Q3 2014.